Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

BioXcel Therapeutics, Inc. (BTAI) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2023 4 Bray June (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $17.52, valued at $297.8k
06/28/2023 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $17.52, valued at $297.8k
06/28/2023 4 MILLER MICHAEL PATRICK (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $17.52, valued at $297.8k
06/28/2023 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $17.52, valued at $297.8k
06/28/2023 4 Votruba Michal (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $17.52, valued at $297.8k
Disposed of 17,000 options to buy @ $17.52, valued at $297.8k
06/16/2023 4 Rodriguez Javier (See Remarks) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 521 restricted stock units @ $0
06/16/2023 4 Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 521 restricted stock units @ $0
06/16/2023 4 Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 521 restricted stock units @ $0
06/16/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 21,988 shares @ $21.41, valued at $470.8k
Sold 8,012 shares @ $21.9, valued at $175.5k
Sold 24,987 shares @ $20.01, valued at $500k
Sold 4,266 shares @ $20.9, valued at $89.2k
Sold 747 shares @ $21.89, valued at $16.4k
Exercised 2,609 restricted stock units @ $0
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
06/16/2023 4 O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 521 restricted stock units @ $0
05/24/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 6,500 shares @ $25.7909, valued at $167.6k
05/16/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 15,000 restricted stock units @ $0
05/16/2023 4 Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 5,000 shares @ $27.1727, valued at $135.9k
Exercised 5,000 restricted stock units @ $0
05/16/2023 4 Rodriguez Javier (See Remarks) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 1,785 shares @ $27.3192, valued at $48.8k
Exercised 5,000 restricted stock units @ $0
03/22/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 24,667 shares @ $18.2, valued at $448.9k
Sold 5,333 shares @ $18.86, valued at $100.6k
Sold 3,896 shares @ $18.22, valued at $71k
Sold 604 shares @ $18.88, valued at $11.4k
Sold 29,100 shares @ $19.7, valued at $573.3k
Sold 900 shares @ $20.15, valued at $18.1k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
03/16/2023 4 Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 2,084 shares @ $19.5, valued at $40.6k
Exercised 2,084 restricted stock units @ $0
Granted 9,000 restricted stock units @ $0
Granted 32,000 options to buy @ $19.6, valued at $627.2k
03/16/2023 4 Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 985 shares @ $19.6911, valued at $19.4k
Exercised 2,084 restricted stock units @ $0
Granted 9,000 restricted stock units @ $0
Granted 32,000 options to buy @ $19.6, valued at $627.2k
03/16/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 10,437 restricted stock units @ $0
Granted 56,000 restricted stock units @ $0
Granted 168,000 options to buy @ $19.6, valued at $3.3M
03/16/2023 4 O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 845 shares @ $19.695, valued at $16.6k
Exercised 2,084 restricted stock units @ $0
Granted 9,000 restricted stock units @ $0
Granted 32,000 options to buy @ $19.6, valued at $627.2k
03/16/2023 4 Wiley Matthew T. (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 12,000 restricted stock units @ $0
Granted 36,000 options to buy @ $19.6, valued at $705.6k
03/16/2023 4 Rodriguez Javier (See Remarks) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 950 shares @ $19.625, valued at $18.6k
Exercised 2,084 restricted stock units @ $0
Granted 9,000 restricted stock units @ $0
Granted 32,000 options to buy @ $19.6, valued at $627.2k
01/24/2023 4 Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 50,000 shares @ $30, valued at $1.5M
01/24/2023 4 O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 29,713 shares @ $30, valued at $891.4k
Exercised 29,713 options to buy @ $0.41, valued at $12.2k
01/06/2023 4 Nandabalan Krishnan (10% Owner) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 24,290 shares @ $21.59, valued at $524.4k
Sold 9,821 shares @ $22.21, valued at $218.1k
Sold 25,089 shares @ $22.32, valued at $560k
Sold 800 shares @ $22.93, valued at $18.3k
Exercised 34,111 options @ $0.41, valued at $14k
Exercised 25,889 options @ $0.41, valued at $10.6k
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Bray June (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $13.24, valued at $225.1k
05/23/2022 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $13.24, valued at $225.1k
05/23/2022 4 Votruba Michal (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $13.24, valued at $225.1k
Disposed of 17,000 options to buy @ $13.24, valued at $225.1k
05/23/2022 4 Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $13.24, valued at $225.1k
05/17/2022 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 15,000 restricted stock units @ $0
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Rodriguez Javier (See Remarks) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 5,000 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy